Summary of Significant Accounting Policies (Tables)

3 Months Ended

Mar. 31, 2020

Accounting Policies [Abstract]

Schedule of Cash and Cash Equivalents

The following table sets forth the components of the Company’s cash, cash equivalents, and restricted cash as reported in the condensed consolidated statement of cash flows for the three month periods ended March 31, 2020 and 2019 (in thousands):

Cash, Cash Equivalents, and Restricted Cash	Three Months Ended March 31,
	2020		2019
Cash and cash equivalents	$	72,181	$	184,090
Restricted cash	730		785
Total cash, cash equivalents, and restricted cash	$	72,911	$	184,875

Restrictions on Cash and Cash Equivalents

The following table sets forth the components of the Company’s cash, cash equivalents, and restricted cash as reported in the condensed consolidated statement of cash flows for the three month periods ended March 31, 2020 and 2019 (in thousands):

Cash, Cash Equivalents, and Restricted Cash	Three Months Ended March 31,
	2020		2019
Cash and cash equivalents	$	72,181	$	184,090
Restricted cash	730		785
Total cash, cash equivalents, and restricted cash	$	72,911	$	184,875

Basis Used to Measure the Fair Value of Financial Instruments

The following table summarizes the basis used to measure the fair values of the Company’s financial instruments (amounts in thousands):

			Fair Value Measurements at Reporting Date, Using:
Description	March 31, 2020		Quoted Prices in Active Markets for Identical Items (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Cash and cash equivalents	$	72,181	$	72,181	$	—	$	—

Description	December 31, 2019		Quoted Prices in Active Markets for Identical Items (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Cash and cash equivalents	$	144,804	$	144,804	$	—	$	—